Digital x-ray and PACS firm Visaris Americas has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Avanse software platform.
Avanse is central to the Visaris360 software portfolio, the company said. It integrates with Visaris Americas' Vision line of digital radiography (DR) systems.
Visaris Americas was launched in October as a new business division of digital x-ray service firm First Source.
